DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 205931
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
The generic ingredient in ACTICLATE is doxycycline hyclate. There are twenty-eight drug master file entries for this compound. Seventy-seven suppliers are listed for this compound. Additional details are available on the doxycycline hyclate profile page.
Summary for 205931
Tradename: | ACTICLATE |
Applicant: | Almirall |
Ingredient: | doxycycline hyclate |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Suppliers and Packaging for NDA: 205931
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ACTICLATE | doxycycline hyclate | TABLET;ORAL | 205931 | NDA | Actavis Pharma, Inc. | 0591-6100 | 0591-6100-60 | 60 TABLET, FILM COATED in 1 BOTTLE (0591-6100-60) |
ACTICLATE | doxycycline hyclate | TABLET;ORAL | 205931 | NDA | Actavis Pharma, Inc. | 0591-6125 | 0591-6125-60 | 60 TABLET, FILM COATED in 1 BOTTLE (0591-6125-60) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 75MG BASE | ||||
Approval Date: | Jul 25, 2014 | TE: | AB | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 150MG BASE | ||||
Approval Date: | Jul 25, 2014 | TE: | AB | RLD: | Yes |
Complete Access Available with Subscription